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FSIFG’s results:
Significant increases in blood concentration were observed: for THC from µ2010=3.44±0.13 ng/mL to 
µ2013=4.23±0.17 ng/mL, p < 0.001, for THCCOOH from µ2010=19.96±0.74 ng/mL to µ2013=28.57±1.10 
ng/mL, p < 0.001.
For the last four years, the number of NEG results has  been stable (13.21 % in 2013, 15.06 % in 2012, 
16.18 % in 2011 and 14.21 % in 2010, ns, only for FSIFG) when the proportions of D and Q changed 
between 2010 and 2013, THC: proportion of Q rise from 27.78% to 46.26%, p < 0.001; 11-OHTHC: from 
5.89% to 18.45%, p < 0.001; THCCOOH: from 77.85% to 85.19%, p = 0.002.
LAT LUMTOX’s results:
Significant increases in blood concentration were observed: for THC from µ2010=3.40±0.14 ng/mL to 
µ2013=5.26±0.10 ng/mL, p < 0.001, for THCCOOH from µ2010=19.67±0.64 ng/mL to µ2013=33.15±0.51 
ng/mL, p < 0.001, for 11-OHTHC from µ2010=1.66±0.06 ng/mL to µ2013=3.01±0.05 ng/mL, p < 0.001.
The proportions of D and Q changed between 2010 and 2013, THC: from 84.25% to 90.72%, p < 0.001, 
11OHTHC: from 73.15% to 82.93%, p < 0.001. THCCOOH calculations were impossible because we 
didn’t distinguish the confirmation requests with and without positive screening test.
RESULTS
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• Even though the results obtained by the LAT LUMTOX were slightly different (absence of negative results) and obtained with another analytical method than 
FSIG’s, they confirmed our past observations of an increase in blood concentrations of cannabinoids in drivers.
• Several hypotheses could explain this observation:
– an evolution of the practices of police officers. They now work closer to the drivers and participate more in the intervention. 
Consequently, they might reduce the wait between screening and sampling. Since the introduction of oral fluid screening tests, the only 
step requiring an health practitioner has been for blood sampling when positive,
– the change of oral fluid screening test during the last four years (from Rapidstat® to Drugwipe®),
– the increase in THC content of consumed products, especially cannabis resins (INPS, 2013; OFDT, 2013).
• This final observation was established when the lab environments were stable (methods, equipment, team and customers) which ruled out laboratory influence, 
therefore must be because of an external reason. Our observations are also reinforced by the similar results of a Norwegian study (Vindenes, 2013).
• A field study of police-officer’s practises could confirm or refute our first hypothesis; the others will be more difficult to investigate.
In 2008, the French government decided to set up oral-fluid drug screening in 
drivers. This new practice modified the customs of police officers and the number of 
screenings and confirming tests increased dramatically. Since this change, we have 
consequently observed an increase in blood concentrations of cannabinoids without 
any modifications in our lab procedures.
In trying to understand this rise and to confirm this observation, we extended our 
study to include another lab. Results were reviewed by both LAT LUMTOX lab and 
FSIFG’s forensic toxicology unit and data was obtained between 2010 and 2013 for 
the following substances: Δ9-tetrahydrocannabinol (THC), 11-nor-9-carboxy-THC
(THCCOOH) and 11-hydroxy-THC (11-OHTHC). Results were classified as “non-
detected” (ND), “detected” (D) and “quantified” (Q) and if no substance was 
detected, results were considered negative (NEG).
Parametric statistics were carried out using χ² tests and ANOVA-1 performed with 
GraphPad Prism 5.0® software. Since 2010, the number of NEG has still been 
stable (ns) when the proportions of D and Q changed significantly. Significant 
increases in blood concentration of all cannabinoids were also observed (e.g. LAT
LUMTOX for THC from µ2010=3.40±0.14 ng/mL to µ2013=5.26±0.10 ng/mL, p<0.001).
The results from LAT LUMTOX confirmed the increase in blood concentrations of 
cannabinoids in drivers. 
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 Since 2008, oral fluid has been used as screening sample by police 
officers from both forces (Police Nationale and Gendarmerie Nationale) 
(Roussel, 2014)
 European toxicologists reported an increase in blood concentrations of 
cannabinoids in people who were screened positive to cannabis usage 
during the last decade (Vindenes, 2013; Jones, 2008)
 Increase in THC content of cannabis resins for 10 years (Jones, 2008)
 In 2003, we reported the same increase in blood concentrations of 
cannabinoids among confirmation blood samples tested in our lab from 
2010 to 2012 (Coste, 2013)
ABSTRACT
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DISCUSSION - CONCLUSIONS
MATERIALS AND METHODS
Data analysis:
• Retrospective analysis of GC/MS confirmation analysis results for cannabinoids 
(THC, THCCOOH and 11-OHTHC) obtained by FSIFG and LAT LUMTOX after 
urinary or oral fluid screening:
AIMS
Confirm our past observations by :
 The analysis of our results from 2013
 The analysis of the results from another lab : LAT LUMTOX
Try to understand the rise of blood concentrations of cannabinoids
• Distribution of the results in 3 categories:  
– “not detected” (ND) when not identified by comparison of retention time and 
spectrum (LLD at 0,1 or 1*ng/mL), 
– “detected” (D) when identified but under the LLQ. The mean of LLD and LLQ 
was allocated to those results for the parametric statistics, and, 
– “quantified” (Q) when upper to LLQ (0,5 or 3*ng/mL). When all the 3 
cannabinoids were not detected, results is categorized “negative” (NEG).
• χ² tests and 1 way ANOVA with Bonferroni’s post-tests were performed with
GraphPad Prism 5.0® software.
* Because the LLD and LLQ for cannabinoids was 1 and 3 ng/mL in 2010, those thresholds were 
kept for all the calculations of FSIFG’s results (there are currently 0,5 ng/mL).
negative no detected (ND) detected (D) quantified (Q)
no detected (ND) detected (D) quantified (Q)
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